| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―13 |
Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance |
Julia M. Flynn, Sarah N. Zvornicanin, Tenzin Tsepal, Ala M. Shaqra, Nese Kurt Yilmaz, Weiping Jia, Stephanie Moquin, Dustin Dovala, Celia A. Schiffer, Daniel N. A. Bolon |
| 2 |
[GO] |
2024―Feb―27 |
Synergistic Binding of SARS-CoV-2 to ACE2 and Gangliosides in Native Lipid Membranes |
Manorama Dey, Anurag Sharma, Garvita Dhanawat, Divya Gupta, Krishnan H. Harshan, Nagma Parveen |
| 3 |
[GO] |
2024―Feb―22 |
Ubiquitin Ligase Parkin Regulates the Stability of SARS-CoV-2 Main Protease and Suppresses Viral Replication |
Li Zhou, Ruochuan Liu, Heather Pathak, Xiaoyu Wang, Geon H. Jeong, Pratima Kumari, Mukesh Kumar, Jun Yin |
| 4 |
[GO] |
2024―Jan―28 |
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation |
Blake M. Hauser, Maya Sangesland, Evan C. Lam, Kerri J. St Denis, Maegan L. Sheehan, Mya L. Vu, Agnes H. Cheng, Sophia Sordilla, Dana Thornlow Lamson, Ahmad W. Almawi, Alejandro B. Balazs, Daniel Lingwood, Aaron G. Schmidt |
| 5 |
[GO] |
2024―Jan―25 |
A Mechanistic Understanding of the Modes of Ca2+ Ion Binding to the SARS-CoV-1 Fusion Peptide and Their Role in the Dynamics of Host Membrane Penetration |
Juliana Debrito Carten, George Khelashvili, Miya K. Bidon, Marco R. Straus, Tiffany Tang, Javier A. Jaimes, Gary R. Whittaker, Harel Weinstein, Susan Daniel |
| 6 |
[GO] |
2024―Jan―09 |
Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease |
Md Ashraf-Uz-Zaman, Teck Khiang Chua, Xin Li, Yuan Yao, Bala Krishna Moku, Chandra Bhushan Mishra, Vasanthi Avadhanula, Pedro A. Piedra, Yongcheng Song |
| 7 |
[GO] |
2023―Oct―18 |
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions |
Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, Hayata Imamura, Francesco Pappone, Alfio Grillo, Maiko Nakashio, Masaharu Shin-Ya, Tetsuya Adachi, Toshiro Yamamoto, Narisato Kanamura, Elia Marin, Wenliang Zhu, Tohru Inaba, Yoko Tanino, Yoko Nukui, Koichiro Higasa, Yoshiki Yasukochi, Kazu Okuma, Osam Mazda |
| 8 |
[GO] |
2023―Oct―03 |
Elevated Level of Circulating but Not Urine S100A8/A9 Identifies Poor COVID-19 Outcomes |
Leah Mellett, Gaya Amarasinghe, Christopher W. Farnsworth, Shabaana A. Khader |
| 9 |
[GO] |
2023―Sep―20 |
Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors |
Nicole L. Inniss, Ján Kozic, Fengling Li, Monica Rosas-Lemus, George Minasov, Jiří Rybáček, Yingjie Zhu, Radek Pohl, Ludmilla Shuvalova, Lubomír Rulíšek, Joseph S. Brunzelle, Lucie Bednárová, Milan Štefek, Ján Michael Kormaník, Erik Andris, Jaroslav Šebestík, Alice Shi Ming Li, Peter J. Brown, Uli Schmitz, Kumar Saikatendu, Edcon Chang, Radim Nencka, Masoud Vedadi, Karla J. F. Satchell |
| 10 |
[GO] |
2023―Jun―30 |
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease |
Julia M. Flynn, Qiu Yu J. Huang, Sarah N. Zvornicanin, Gila Schneider-Nachum, Ala M. Shaqra, Nese Kurt Yilmaz, Stephanie A. Moquin, Dustin Dovala, Celia A. Schiffer, Daniel N.A. Bolon |
| 11 |
[GO] |
2023―May―11 |
hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics |
Chengbo Chen, Richard Zhu, Edgar A. Hodge, Marco A. Díaz-Salinas, Adam Nguyen, James B. Munro, Kelly K. Lee |
| 12 |
[GO] |
2023―May―05 |
SARS-CoV-2 Binding to Terminal Sialic Acid of Gangliosides Embedded in Lipid Membranes |
Geetanjali Negi, Anurag Sharma, Monika Chaudhary, Divya Gupta, Krishnan H. Harshan, Nagma Parveen |
| 13 |
[GO] |
2023―Apr―13 |
Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells |
Corina M. Stewart, Yuxia Bo, Kathy Fu, Mable Chan, Robert Kozak, Kim Yang-Ping Apperley, Geneviève Laroche, Redaet Daniel, André M. Beauchemin, Gary Kobinger, Darwyn Kobasa, Marceline Côté |
| 14 |
[GO] |
2023―Apr―03 |
Identification of Human Host Substrates of the SARS-CoV-2 Mpro and PLpro Using Subtiligase N-Terminomics |
Shu Y. Luo, Eman W. Moussa, Joaquin Lopez-Orozco, Alberto Felix-Lopez, Ray Ishida, Nawell Fayad, Erik Gomez-Cardona, Henry Wang, Joyce A. Wilson, Anil Kumar, Tom C. Hobman, Olivier Julien |
| 15 |
[GO] |
2023―Mar―13 |
Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 |
Hyeon-Min Cha, Uk-Il Kim, Soo Bin Ahn, Myoung Kyu Lee, Haemi Lee, Hyungtae Bang, Yejin Jang, Seong Soon Kim, Myung Ae Bae, Kyungjin Kim, Meehyein Kim |
| 16 |
[GO] |
2023―Feb―03 |
Hybridization Chain Reaction Lateral Flow Assays for Amplified Instrument-Free At-Home SARS-CoV-2 Testing |
Samuel J. Schulte, Jining Huang, Niles A. Pierce |
| 17 |
[GO] |
2022―Oct―31 |
High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2 |
Rachel M. Sammons, Amanda L. Bohanon, Anvith Kowtha, Audrey Dejong, Eun Jeong Cho, Tamer S. Kaoud, Kevin N. Dalby |
| 18 |
[GO] |
2022―Oct―11 |
α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade |
Rui Qin, Emma Kurz, Shuhui Chen, Briana Zeck, Luis Chiribogas, Dana Jackson, Alex Herchen, Tyson Attia, Michael Carlock, Amy Rapkiewicz, Dafna Bar-Sagi, Bruce Ritchie, Ted M. Ross, Lara K. Mahal |
| 19 |
[GO] |
2022―Sep―26 |
Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry |
Sneha Ratnapriya, Anthony R. Braun, Héctor Cervera Benet, Danielle Carlson, Shilei Ding, Carolyn N. Paulson, Neeraj Mishra, Jonathan N. Sachs, Courtney C. Aldrich, Andrés Finzi, Alon Herschhorn |
| 20 |
[GO] |
2022―Sep―21 |
Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells |
Chandra Shekhar Kumar, Balwant Singh, Zaigham Abbas Rizvi, Hilal Ahmad Parray, Jitender Kumar Verma, Sukanya Ghosh, Amitabha Mukhopadhyay, Amit Awasthi, Tripti Shrivastava, Manidipa Banerjee |
| 21 |
[GO] |
2022―Sep―12 |
Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions |
Yongheng Rong, Xingyun Wang, Weian Mao, Fang Yuan, Min Chen, Shengjun Wang, Peng George Wang, Zhigang Wu, Yunjiao He, Yun Kong |
| 22 |
[GO] |
2022―Aug―31 |
A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses |
Ya-Qian Li, Cheng Yan, Xi-Feng Wang, Mao-Ying Xian, Guo-Qing Zou, Xiao-Fei Gao, Rui Luo, Zheng Liu |
| 23 |
[GO] |
2022―Aug―18 |
Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity |
Ebba Samuelsson, Ekaterina Mirgorodskaya, Kristina Nyström, Malin Bäckström, Jan-Åke Liljeqvist, Rickard Nordén |
| 24 |
[GO] |
2022―Aug―08 |
Two Years into the COVID-19 Pandemic: Lessons Learned |
Severino Jefferson Ribeiro da Silva, Jessica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, Klarissa Miranda Guarines, Caroline Targino Alves da Silva, Poliana Gomes da Silva, Jurandy Júnior Ferraz de Magalhães, Justin R. J. Vigar, Abelardo Silva-Júnior, Alain Kohl, Keith Pardee, Lindomar Pena |
| 25 |
[GO] |
2022―Jul―22 |
Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2 |
Abraham J. Qavi, Chao Wu, Matthew Lloyd, Mohammad Mahabub-Uz Zaman, Jingyi Luan, Claire Ballman, Daisy W. Leung, Scott L. Crick, Christopher W. Farnsworth, Gaya K. Amarasinghe |
| 26 |
[GO] |
2022―Jul―13 |
Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors |
Aliakbar Khalili Yazdi, Paknoosh Pakarian, Sumera Perveen, Taraneh Hajian, Vijayaratnam Santhakumar, Albina Bolotokova, Fengling Li, Masoud Vedadi |
| 27 |
[GO] |
2022―Jul―12 |
Raman Fingerprints of the SARS-CoV-2 Delta Variant and Mechanisms of Its Instantaneous Inactivation by Silicon Nitride Bioceramics |
Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, Hayata Imamura, Masaharu Shin-Ya, Tetsuya Adachi, Toshiro Yamamoto, Narisato Kanamura, Elia Marin, Wenliang Zhu, Ichiro Nishimura, Osam Mazda |
| 28 |
[GO] |
2022―Jun―29 |
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity |
Marie O. Pohl, Laura Martin-Sancho, Ranjala Ratnayake, Kris M. White, Laura Riva, Qi-Yin Chen, Gauthier Lieber, Idoia Busnadiego, Xin Yin, Samuel Lin, Yuan Pu, Lars Pache, Romel Rosales, Marion Déjosez, Yiren Qin, Paul D. De Jesus, Anne Beall, Sunnie Yoh, Benjamin G. Hale, Thomas P. Zwaka, Naoko Matsunaga, Adolfo García-Sastre, Silke Stertz, Sumit K. Chanda, Hendrik Luesch |
| 29 |
[GO] |
2022―Jun―24 |
Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern |
Ru-Yan Zhang, Shi-Hao Zhou, Chen-Bin He, Jian Wang, Yu Wen, Ran-Ran Feng, Xu-Guang Yin, Guang-Fu Yang, Jun Guo |
| 30 |
[GO] |
2022―Jun―01 |
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19 |
Jonathan H. Shrimp, John Janiszewski, Catherine Z. Chen, Miao Xu, Kelli M. Wilson, Stephen C. Kales, Philip E. Sanderson, Paul Shinn, Rick Schneider, Zina Itkin, Hui Guo, Min Shen, Carleen Klumpp-Thomas, Samuel G. Michael, Wei Zheng, Anton Simeonov, Matthew D. Hall |
| 31 |
[GO] |
2022―May―24 |
Pyronaridine Protects against SARS-CoV-2 Infection in Mouse |
Ana C. Puhl, Giovanni F. Gomes, Samara Damasceno, Andre S. Godoy, Gabriela D. Noske, Aline M. Nakamura, Victor O. Gawriljuk, Rafaela S. Fernandes, Natalia Monakhova, Olga Riabova, Thomas R. Lane, Vadim Makarov, Flavio P. Veras, Sabrina S. Batah, Alexandre T. Fabro, Glaucius Oliva, Fernando Q. Cunha, José C. Alves-Filho, Thiago M. Cunha, Sean Ekins |
| 32 |
[GO] |
2022―Apr―15 |
A Highly Potent SARS-CoV-2 Blocking Lectin Protein |
Recep E. Ahan, Alireza Hanifehnezhad, Ebru Ş. Kehribar, Tuba C. Oguzoglu, Katalin Földes, Cemile E. Özçelik, Nazlican Filazi, Sıdıka Öztop, Fahreddin Palaz, Sevgen Önder, Eray U. Bozkurt, Koray Ergünay, Aykut Özkul, Urartu Özgür Şafak Şeker |
| 33 |
[GO] |
2022―Apr―11 |
Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor |
Chunlong Ma, Yanmei Hu, Yuyin Wang, Juliana Choza, Jun Wang |
| 34 |
[GO] |
2022―Mar―30 |
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 |
Viola Denninger, Catherine K. Xu, Georg Meisl, Alexey S. Morgunov, Sebastian Fiedler, Alison Ilsley, Marc Emmenegger, Anisa Y. Malik, Monika A. Piziorska, Matthias M. Schneider, Sean R. A. Devenish, Vasilis Kosmoliaptsis, Adriano Aguzzi, Heike Fiegler, Tuomas P. J. Knowles |
| 35 |
[GO] |
2022―Mar―14 |
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks |
Kirandeep Samby, Dominique Besson, Anirban Dutta, Buddhadev Patra, Angelique Doy, Paul Glossop, James Mills, Gavin Whitlock, Rob Hooft van Huijsduijnen, Alessandra Monaco, Graeme Bilbe, Charles Mowbray, Benjamin Perry, Anna Adam, Timothy N. C. Wells, Paul A. Willis |
| 36 |
[GO] |
2022―Mar―09 |
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant |
Albert To, Teri Ann S. Wong, Michael M. Lieberman, Karen Thompson, Aquena H. Ball, Laurent Pessaint, Jack Greenhouse, Nisrine Daham, Anthony Cook, Brandon Narvaez, Zack Flinchbaugh, Alex Van Ry, Jake Yalley-Ogunro, Hanne Andersen Elyard, Chih-Yun Lai, Oreola Donini, Axel T. Lehrer |
| 37 |
[GO] |
2022―Feb―24 |
Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses |
Brendan T. Freitas, Daniil A. Ahiadorme, Rahul S. Bagul, Ian A. Durie, Samir Ghosh, Jarvis Hill, Naomi E. Kramer, Jackelyn Murray, Brady M. O’Boyle, Emmanuel Onobun, Michael G. Pirrone, Justin D. Shepard, Suzanne Enos, Yagya P. Subedi, Kapil Upadhyaya, Ralph A. Tripp, Brian S. Cummings, David Crich, Scott D. Pegan |
| 38 |
[GO] |
2022―Feb―23 |
Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery |
Rumiana Tenchov, Qiongqiong Angela Zhou |
| 39 |
[GO] |
2022―Feb―08 |
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants |
Rui Wang, Jiahui Chen, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei |
| 40 |
[GO] |
2021―Dec―03 |
Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview |
Rukmankesh Mehra, Kasper P. Kepp |
| 41 |
[GO] |
2021―Oct―21 |
Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus |
Oscar A. Ortega-Rivera, Sourabh Shukla, Matthew D. Shin, Angela Chen, Veronique Beiss, Miguel A. Moreno-Gonzalez, Yi Zheng, Alex E. Clark, Aaron F. Carlin, Jonathan K. Pokorski, Nicole F. Steinmetz |
| 42 |
[GO] |
2021―Oct―19 |
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern |
Madalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, Kathy Fu, Geneviève Laroche, Zaid Taha, Demi van der Horst, Lena Cassin, Renée M. van der Sluis, Enrico Palermo, Daniele Di Carlo, David Jacobs, Glib Maznyi, Taha Azad, Ragunath Singaravelu, Fanghui Ren, Anne Louise Hansen, Manja Idorn, Christian K. Holm, Martin R. Jakobsen, Julien van Grevenynghe, John Hiscott, Søren R. Paludan, John C. Bell, Jean Seguin, Luc A. Sabourin, Marceline Côté, Jean-Simon Diallo, Tommy Alain, David Olagnier |
| 43 |
[GO] |
2021―Oct―07 |
Reductionism Ad Absurdum: The Misadventures of Structural Biology in the Time of Coronavirus |
Dmitri Svetlov, Irina Artsimovitch |
| 44 |
[GO] |
2021―Sep―27 |
A Closer Look into FDA-EUA Approved Diagnostic Techniques of Covid-19 |
Hyunju Oh, Hyunjeong Ahn, Anubhav Tripathi |
| 45 |
[GO] |
2021―Sep―09 |
Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread |
Marco R. Straus, Miya K. Bidon, Tiffany Tang, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel |
| 46 |
[GO] |
2021―Aug―26 |
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease |
Elizabeth A. MacDonald, Gary Frey, Mark N. Namchuk, Stephen C. Harrison, Stephen M. Hinshaw, Ian W. Windsor |
| 47 |
[GO] |
2021―Aug―02 |
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model |
Steven Blake, Namir Shaabani, Lisa M. Eubanks, Junki Maruyama, John T. Manning, Nathan Beutler, Slobodan Paessler, Henry Ji, John R. Teijaro, Kim D. Janda |
| 48 |
[GO] |
2021―Jul―30 |
Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis |
Rachna Singh, Anjna Kumari |
| 49 |
[GO] |
2021―Jul―28 |
Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection |
Amalia Z. Berna, Elikplim H. Akaho, Rebecca M. Harris, Morgan Congdon, Emilie Korn, Samuel Neher, Mirna M’Farrej, Julianne Burns, Audrey R. Odom John |
| 50 |
[GO] |
2021―Jul―14 |
Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative |
Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S. Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, Sara Khaleeq, Petrus Jansen van Vuren, Shane Riddell, Sarah Goldie, Savitha Gayathri, Debajyoti Chakraborty, Parismita Kalita, Ishika Pramanick, Nupur Agarwal, Poorvi Reddy, Nidhi Girish, Aditya Upadhyaya, Mohammad Suhail Khan, Kawkab Kanjo, Madhuraj Bhat, Shailendra Mani, Sankar Bhattacharyya, Samreen Siddiqui, Akansha Tyagi, Sujeet Jha, Rajesh Pandey, Shashank Tripathi, Somnath Dutta, Alexander J. McAuley, Nagendrakumar Balasubramanian Singanallur, Seshadri S. Vasan, Rajesh P. Ringe, Raghavan Varadarajan |
| 51 |
[GO] |
2021―Jun―21 |
The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors |
Tomáš Otava, Michal Šála, Fengling Li, Jindřich Fanfrlík, Kanchan Devkota, Sumera Perveen, Irene Chau, Paknoosh Pakarian, Pavel Hobza, Masoud Vedadi, Evzen Boura, Radim Nencka |
| 52 |
[GO] |
2021―Jun―15 |
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2 |
Scott B. Biering, Erik Van Dis, Eddie Wehri, Livia H. Yamashiro, Xammy Nguyenla, Claire Dugast-Darzacq, Thomas G. W. Graham, Julien R. Stroumza, Guillaume R. Golovkine, Allison W. Roberts, Daniel M. Fines, Jessica N. Spradlin, Carl C. Ward, Teena Bajaj, Dustin Dovala, Ursula Schulze-Gamen, Ruchika Bajaj, Douglas M. Fox, Melanie Ott, Niren Murthy, Daniel K. Nomura, Julia Schaletzky, Sarah A. Stanley |
| 53 |
[GO] |
2021―Jun―03 |
Science at Its Best in the Time of the COVID-19 Pandemic |
Alon Herschhorn, Ashley T. Haase |
| 54 |
[GO] |
2021―May―26 |
Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp |
Jianyuan Zhao, Yongxin Zhang, Minghua Wang, Qian Liu, Xiaobo Lei, Meng Wu, SaiSai Guo, Dongrong Yi, Quanjie Li, Ling Ma, Zhenlong Liu, Fei Guo, Jianwei Wang, Xiaoyu Li, Yucheng Wang, Shan Cen |
| 55 |
[GO] |
2021―May―21 |
The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease |
Nathanael D. Reynolds, Nathalie M. Aceves, Jinny L. Liu, Jaimee R. Compton, Dagmar H. Leary, Brendan T. Freitas, Scott D. Pegan, Katarina Z. Doctor, Fred Y. Wu, Xin Hu, Patricia M. Legler |
| 56 |
[GO] |
2021―May―12 |
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 |
Damir Bojadzic, Oscar Alcazar, Jinshui Chen, Sung-Ting Chuang, Jose M. Condor Capcha, Lina A. Shehadeh, Peter Buchwald |
| 57 |
[GO] |
2021―Apr―21 |
Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum |
Sebastian Fiedler, Monika A. Piziorska, Viola Denninger, Alexey S. Morgunov, Alison Ilsley, Anisa Y. Malik, Matthias M. Schneider, Sean R. A. Devenish, Georg Meisl, Vasilis Kosmoliaptsis, Adriano Aguzzi, Heike Fiegler, Tuomas P. J. Knowles |
| 58 |
[GO] |
2021―Apr―16 |
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone |
Cheng Wang, Shaobo Wang, Daixi Li, Peiqin Chen, Songling Han, Gaomei Zhao, Yin Chen, Jianqi Zhao, Jiachuan Xiong, Jingfei Qiu, Dong-Qing Wei, Jinghong Zhao, Junping Wang |
| 59 |
[GO] |
2021―Mar―30 |
Inhibition of Human Coronaviruses by Antimalarial Peroxides |
Ayan Kumar Ghosh, Halli Miller, Konstance Knox, Madhuchhanda Kundu, Kelly J. Henrickson, Ravit Arav-Boger |
| 60 |
[GO] |
2021―Mar―17 |
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2 |
Simon Fink, Felix Ruoff, Aaron Stahl, Matthias Becker, Philipp Kaiser, Bjoern Traenkle, Daniel Junker, Frank Weise, Natalia Ruetalo, Sebastian Hörber, Andreas Peter, Annika Nelde, Juliane Walz, Gérard Krause, Armin Baillot, Katja Schenke-Layland, Thomas O. Joos, Ulrich Rothbauer, Nicole Schneiderhan-Marra, Michael Schindler, Markus F. Templin |
| 61 |
[GO] |
2021―Mar―08 |
Learning from COVID-19 to Tackle Antibiotic Resistance |
Manica Balasegaram |
| 62 |
[GO] |
2021―Mar―01 |
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses |
Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang |
| 63 |
[GO] |
2021―Feb―13 |
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19 |
Kas Steuten, Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, Scott Lovell, Oguz Bolgi, Berati Cerikan, Christopher J. Neufeldt, Mirko Cortese, Ryan K. Muir, John M. Bennett, Ruth Geiss-Friedlander, Christoph Peters, Ralf Bartenschlager, Matthew Bogyo |
| 64 |
[GO] |
2021―Jan―27 |
Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia |
Anggia Prasetyoputri |
| 65 |
[GO] |
2021―Jan―15 |
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin |
Tiffany Tang, Javier A. Jaimes, Miya K. Bidon, Marco R. Straus, Susan Daniel, Gary R. Whittaker |
| 66 |
[GO] |
2021―Jan―13 |
Early Returns on Small Molecule Therapeutics for SARS-CoV-2 |
Mark N. Namchuk |
| 67 |
[GO] |
2020―Dec―22 |
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? |
Andrew V. Stachulski, Joshua Taujanskas, Sophie L. Pate, Rajith K. R. Rajoli, Ghaith Aljayyoussi, Shaun H. Pennington, Stephen A. Ward, Weiqian David Hong, Giancarlo A. Biagini, Andrew Owen, Gemma L. Nixon, Suet C. Leung, Paul M. O’Neill |
| 68 |
[GO] |
2020―Dec―21 |
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules |
Kirill Gorshkov, Catherine Z. Chen, Robert Bostwick, Lynn Rasmussen, Bruce Nguyen Tran, Yu-Shan Cheng, Miao Xu, Manisha Pradhan, Mark Henderson, Wei Zhu, Eunkeu Oh, Kimihiro Susumu, Mason Wolak, Khalida Shamim, Wenwei Huang, Xin Hu, Min Shen, Carleen Klumpp-Thomas, Zina Itkin, Paul Shinn, Juan Carlos de la Torre, Anton Simeonov, Sam G. Michael, Matthew D. Hall, Donald C. Lo, Wei Zheng |
| 69 |
[GO] |
2020―Dec―15 |
Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic |
Brayden G. Schindell, Meagan Allardice, Sandhini Lockman, Jason Kindrachuk |
| 70 |
[GO] |
2020―Dec―09 |
Recent Insights into Emerging Coronavirus: SARS-CoV-2 |
Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang |
| 71 |
[GO] |
2020―Dec―02 |
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies |
Jonathan P. Davies, Katherine M. Almasy, Eli F. McDonald, Lars Plate |
| 72 |
[GO] |
2020―Nov―18 |
Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry |
Nicholas L. Dollman, Justin H. Griffin, Kevin M. Downard |
| 73 |
[GO] |
2020―Nov―13 |
High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2 |
Weiwei Wan, Shenglin Zhu, Shufen Li, Weijuan Shang, Ruxue Zhang, Hao Li, Wei Liu, Gengfu Xiao, Ke Peng, Leike Zhang |
| 74 |
[GO] |
2020―Nov―12 |
COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection? |
Adnan Hodžić, José de la Fuente, Alejandro Cabezas-Cruz |
| 75 |
[GO] |
2020―Oct―28 |
Targeting Crucial Host Factors of SARS-CoV-2 |
Anil Mathew Tharappel, Subodh Kumar Samrat, Zhong Li, Hongmin Li |
| 76 |
[GO] |
2020―Sep―23 |
Targeting polyamines inhibits coronavirus infection by reducing cellular attachment |
Mason R Firpo, Vincent Mastrodomenico, Grant Hawkins, Matthieu Prot, Laura Levillayer, Thomas Gallagher, Etienne Simon-Loriere, Bryan Mounce |
| 77 |
[GO] |
2020―Sep―18 |
Structural, biophysical and biochemical elucidation of the SARS-CoV-2 nonstructural protein 3 macro domain |
Meng-Hsuan Lin, San-Chi Chang, Yi-Chih Chiu, Bo-Chen Jiang, Tsung-Han Wu, Chun-Hua Hsu |
| 78 |
[GO] |
2020―Aug―12 |
Comparative analysis of primer-probe sets for RT-qPCR of COVID-19 causative virus (SARS-CoV-2) |
Yujin Jung, Gun-Soo Park, Jun Hye Moon, Keun Bon Ku, Seung-Hwa Beak, Chang-Seop Lee, Seil Kim, Edmond Changkyun Park, Daeui Park, Jong-Hwan Lee, Cheol Woo Byeon, Joong Jin Lee, Jin-Soo Maeng, Seong-Jun Kim, Seung Il Kim, Bum Tae Kim, Min Jun Lee, Hong Gi Kim |
| 79 |
[GO] |
2020―Aug―04 |
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19 |
Severino Jefferson Ribeiro da Silva, Caroline silva, Klarissa Guarines, Renata Mendes, Keith M. Pardee, Alain Kohl, Lindomar Pena |
| 80 |
[GO] |
2020―Jul―20 |
Old drugs for a new virus: repurposed approaches for combating COVID-19 |
Sirle Saul, Shirit Einav |
| 81 |
[GO] |
2020―Jul―17 |
Current and Perspective Diagnostic Techniques for COVID-19 |
Xi Yuan, Chengming Yang, Qian He, Junhu Chen, Dongmei Yu, Jie Li, Shiyao Zhai, Zhifeng Qin, Ke Du, Zhenhai Chu, Peiwu Qin |
| 82 |
[GO] |
2020―Jun―02 |
Current Perspective of Antiviral Strategies against COVID-19 |
Bintou Ahmadou Ahidjo, Marcus Loe, Yan Ling Ng, Chee Keng Mok, Justin Jang Hann Chu |
| 83 |
[GO] |
2020―Jun―01 |
COVID-19 and Other Pandemics: How Might They Be Prevented? |
Eric Oldfield, Satish R. Malwal |
| 84 |
[GO] |
2020―May―28 |
Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients |
Alexey Polonikov |
| 85 |
[GO] |
2020―May―19 |
Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease |
Brendan T Freitas, Ian A Durie, Jackelyn Murray, Jaron E Longo, Holden C Miller, David Crich, Robert Jeff Hogan, Ralph A Tripp, Scott D Pegan |
| 86 |
[GO] |
2020―May―15 |
Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2? |
Cassandra L. Schrank, Kevin P. C. Minbiole, William M. Wuest |
| 87 |
[GO] |
2020―May―10 |
COVID-19: Living through Another Pandemic |
Essam Eldin A. Osman, Peter L. Toogood, Nouri Neamati |
| 88 |
[GO] |
2020―Apr―15 |
Correction: Immunodominant SARS Coronavirus Epitopes in Humans Elicited Both Enhancing and Neutralizing Effects on Infection in Non-human Primates |
Qidi Wang, Lianfeng Zhang, Kazuhiko Kuwahara, Li Li, Zijie Liu, Taisheng Li, Hua Zhu, Jiangning Liu, Yanfeng Xu, Jing Xie, Hiroshi Morioka, Nobuo Sakaguchi, Chuan Qin, Gang Liu |
|
